Oseltamivir Phosphate
Product Images NDC 53002-5387

2 FDA label images from Rpk Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Oseltamivir Phosphate (NDC 53002-5387). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (A1279325 8446 412f 83b1 46ed6c5666c0 01)

Chemical Structure (A1279325 8446 412f 83b1 46ed6c5666c0 01)
Chemical structure diagram of the active ingredient oseltamivir phosphate showing molecular bonds and functional groups consistent with its known chemical makeup.*
FDA Label Image

Label Image (Lbl530025387)

Label Image (Lbl530025387)
Label for Oseltamivir Phosphate 75mg Capsules by RPK Pharmaceuticals, Inc., containing 10 capsules. The label includes directions for use, dosing instructions, usage warnings, and administrative information. Various barcodes and lot numbers are present, alongside prescription status and expiration date information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.